News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celgene (CELG) Discloses Justice Dept Probe Into Drug Marketing


3/2/2011 7:55:42 AM

Wall Street Journal -- Celgene Corp. (CELG) received notice that federal prosecutors are investigating its marketing practices for top-selling blood cancer drug Revlimid. The probe relates to Celgene's promotion of Revlimid, along with a similar drug called Thalomid, "regarding off-label marketing and improper payments to physicians." In a regulatory filing Tuesday, the Summit, N.J., drug maker said it recently received a letter from the U.S. Attorney for the Central District of California about the investigation.


comments powered by Disqus
Celgene
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES